Role of Serotoninergic Antidepressants in the Development of Autism Spectrum Disorders: A Systematic Review
Authors:
- Sheena MathewSMSheena Mathew
- Sumahitha BichenapallySBSumahitha Bichenapally
- Vahe KhachatryanVKVahe Khachatryan
- Asmaa MuazzamAMAsmaa Muazzam
- Chandani HamalCHChandani Hamal
- Lakshmi Sai Deepak Reddy VelugotiLVLakshmi Sai Deepak Reddy Velugoti
- Godfrey TaboweiGTGodfrey Tabowei
- Greeshma N. GaddipatiGGGreeshma N. Gaddipati
- Maria MukhtarMMMaria Mukhtar
- Mohammed J. AlzubaideeMAMohammed J. Alzubaidee
- Raga Sruthi DwarampudiRDRaga Sruthi Dwarampudi
- Michael AlfonsoMAMichael Alfonso
Open Access
- 27 August 2022
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e28505
Abstract
Autism spectrum disorders (ASDs) are one of the most common, highly heritable neurodevelopmental diseases affecting 1-2% of children under the age of 3. Although studies have implicated genetic predispositions, environmental risk factors, and maternal depression as the pathophysiology of ASD, it remains unclear. The association between antidepressant (AD) usage during pregnancy and the likelihood of ASD in children is still debatable. We carried out a systematic review to determine the relation of ASD with AD in offspring exposed to ADs in utero. We used the following terms of medical subject heading (MeSH) and keywords separately and in combination: “antidepressants,” “maternal/pregnancy depression,” “autism spectrum disorders/autism,” and “selective serotonin reuptake inhibitors (SSRI).” Our data search was conducted on PubMed, PubMed Central, Google Scholar, and Cochrane, which resulted in 28,141 articles. We identified and eliminated duplicates and then screened 9,965 articles by title and We then applied eligibility criteria over 143 relevant articles; a quality assessment was performed, and finally we included 18 selected studies. Mothers who had taken ADs during pregnancy for at least two medication prescription cycles and children detected to have ASD from two years to 18 years of age were included. We excluded articles in languages other than English, grey literature, case reports, letters to the editor, books, documents, animal studies, and studies published before 2017. Out of 18 studies, 17 evaluated ASD as the primary outcome, and for one study, the outcome was child behavioral as well as neurodevelopmental changes. Other additional outcomes studied were attention deficit hyperactivity disorder (ADHD), preterm birth, spontaneous abortion, small for gestational age, maternal mental illness, and persistent pulmonary hypertension. After adjusting for confounding factors, in six studies, the higher correlations between ASD and ADs were eliminated. Also, paternal AD use, maternal pre-conceptional AD drug use, and maternal depression itself are additional factors that raise the incidence of ASD.Keywords
This publication has 32 references indexed in Scilit:
- Antidepressants during pregnancy and autism in offspring: population based cohort studyBMJ, 2017
- Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant ExposureBirth Defects Research, 2017
- Risk for Autism Spectrum Disorders According to Period of Prenatal Antidepressant ExposureJAMA Pediatrics, 2017
- Autism risk following antidepressant medication during pregnancyPsychological Medicine, 2017
- Association Between Maternal Use of SSRI Medications and Autism in Their Children.JAMA, 2017
- Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in OffspringJAMA, 2017
- Association Between Serotonergic Antidepressant Use During Pregnancy and Autism Spectrum Disorder in ChildrenJAMA, 2017
- Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: A systematic review and meta-analysisReproductive Toxicology, 2016
- Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in ChildrenJAMA Pediatrics, 2016
- Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control studyBMJ, 2013